Table 6: Immunological, haematological, and biochemical profiles of the population under study stratified by iron status.

ParameterAnaemia ()Iron deficiency ()Iron deficiency anaemia ()Iron overload () value value (trend)

Age36.87 ± 11.2538.23 ± 11.4136.22 ± 10.3738.85 ± 6.520.80020.7059
CD4 (cells/mm3)264.50 ± 84.00322.20 ± 102.80233.10 ± 103.2429.50 ± 124.10.2110.1693
CD3 (cells/mm3)1029.00 ± 425.201154.00 ± 401.001021.00 ± 426.11478.00 ± 452.100.12630.0519
CD4/CD30.23 ± 0.070.25 ± 0.070.19 ± 0.040.29 ± 0.090.23790.4632
WBC (103/μL) 5.06 ± 2.005.31 ± 0.295.57 ± 1.394.72 ± 1.200.60360.7046
Haematological profile
 Hb (g/dL)9.32 ± 1.1710.73 ± 2.198.89 ± 1.3511.75 ± 1.11<0.00010.0008
 RBC (106/μL) 3.43 ± 0.523.86 ± 0.723.45 ± 0.563.79 ± 0.580.00160.2581
 HCT (%)28.89 ± 3.5632.66 ± 6.1327.60 ± 3.8034.29 ± 3.46<0.00010.0155
 MCV (fL)85.41 ± 12.1385.70 ± 12.8081.35 ± 12.3692.12 ± 14.500.09540.1948
 MCH (pg)28.39 ± 5.3029.18 ± 5.3927.18 ± 5.5431.72 ± 4.960.07850.1214
 MCHC (g/dL)33.24 ± 3.2134.05 ± 3.0433.36 ± 3.3734.51 ± 1.150.37220.2879
 RDW-CV 16.61 ± 2.1615.76 ± 2.1816.76 ± 2.0814.98 ± 1.470.01610.0579
 RDW-SD52.59 ± 8.4950.98 ± 6.8650.66 ± 7.5251.02 ± 7.050.63190.4892
 PLT (103/μL) 251.50 ± 91.12252.80 ± 95.10270.60 ± 88.36220.30 ± 97.970.4610.3957
Biochemical profile
 Iron (μmol/L)8.93 ± 2.984.60 ± 1.824.01 ± 2.0749.47 ± 19.94<0.0001<0.0001
 Ferritin (μg/L)229.00 ± 55.13223.80 ± 53.00248.90 ± 62.32193.10 ± 16.690.02150.1106
 Transferrin (mg/dL)290.80 ± 70.02284.20 ± 67.31316.10 ± 79.14245.20 ± 21.200.02150.1106
 TIBC (μg/dL)18.87 ± 7.499.60 ± 2.967.71 ± 2.24112.80 ± 47.94<0.0001<0.0001

values < 0.05 were considered significant. values represent one-way ANOVA of all variables. WBC = White Blood Cells, Hb = haemoglobin, RBC = Red Blood Cells, HCT = haematocrit, MCV = Mean Cell Volume, MCH = Mean Cell Haemoglobin, MCHC = Mean Cell Haemoglobin Concentration, RDW-CV = Red Cell Distribution Width-Cumulative Variance, RDW-SD = Red Cell Distribution Width-Standard Deviation, PLT = platelets, TIBC = Total Iron Binding Capacity, TSAT = transferrin saturation, and HAART = Highly Active Antiretroviral Therapy.